• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study.

作者信息

Kaufmann D, Pantaleo G, Sudre P, Telenti A

出版信息

Lancet. 1998 Mar 7;351(9104):723-4. doi: 10.1016/s0140-6736(98)24010-4.

DOI:10.1016/s0140-6736(98)24010-4
PMID:9504519
Abstract
摘要

相似文献

1
CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study.
Lancet. 1998 Mar 7;351(9104):723-4. doi: 10.1016/s0140-6736(98)24010-4.
2
Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.丙型肝炎病毒（HCV）病毒血症和HCV基因型在一组未接受过抗逆转录病毒治疗的HIV感染个体接受高效抗逆转录病毒治疗后的免疫恢复中的作用。
Clin Infect Dis. 2005 Jun 15;40(12):e101-9. doi: 10.1086/430445. Epub 2005 May 5.
3
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.血浆病毒载量≤20拷贝/毫升的HIV-1感染患者的残余病毒血症与可溶性免疫激活标志物的血液水平升高有关。
Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.
4
Human immunodeficiency virus mutation and changes in CD4 T-cell levels during antiretroviral therapy.抗逆转录病毒治疗期间人类免疫缺陷病毒的突变及CD4 T细胞水平的变化
Eur J Clin Microbiol Infect Dis. 1998 May;17(5):301-3. doi: 10.1007/BF01709450.
5
Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance.对CD4(+)细胞计数与病毒载量长期不一致的HIV感染患者的免疫反应和病毒特征进行纵向评估。
AIDS Res Hum Retroviruses. 2005 Jan;21(1):13-6. doi: 10.1089/aid.2005.21.13.
6
Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children.在感染HIV的儿童中，将司他夫定换为替诺福韦并将蛋白酶抑制剂替换为依非韦伦后血脂异常的改善情况。
Antivir Ther. 2005;10(8):917-24.
7
Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.在瑞士艾滋病毒队列研究中，高效抗逆转录病毒治疗后卡波西肉瘤疱疹病毒抗体反应和病毒血症。
AIDS. 2010 Sep 10;24(14):2245-52. doi: 10.1097/QAD.0b013e32833b7830.
8
[Impact of antiretroviral therapy on the biological profile of HIV positive children followed-up at Yaounde University Hospital in Cameroon].[抗逆转录病毒疗法对喀麦隆雅温得大学医院随访的HIV阳性儿童生物学特征的影响]
Pan Afr Med J. 2015 Feb 19;20:159. doi: 10.11604/pamj.2015.20.159.4677. eCollection 2015.
9
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.作为联合抗逆转录病毒治疗（cART）方案一部分使用的抗逆转录病毒药物与病毒血症得到抑制的患者CD4细胞计数增加之间的关系。
AIDS. 2006 May 12;20(8):1141-50. doi: 10.1097/01.aids.0000226954.95094.39.
10
The case for more cautious, patient-focused antiretroviral therapy.关于更谨慎、以患者为中心的抗逆转录病毒疗法的理由。
Ann Intern Med. 2000 Feb 15;132(4):306-11. doi: 10.7326/0003-4819-132-4-200002150-00009.

引用本文的文献

1
Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral Reactivation.整合单细胞多组学分析 HIV 潜伏逆转揭示了病毒激活的新调控因子。
Genomics Proteomics Bioinformatics. 2024 May 9;22(1). doi: 10.1093/gpbjnl/qzae003.
2
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect.HIV 蛋白酶抑制剂奈非那韦和洛匹那韦/利托那韦可显著改善感染 SARS-CoV-2 的叙利亚仓鼠的肺部病理，尽管它们没有抗病毒作用。
Antiviral Res. 2022 Jun;202:105311. doi: 10.1016/j.antiviral.2022.105311. Epub 2022 Apr 4.
3
Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks.
将绥美凯（Triumeq®）换成仿制药（阿巴卡韦+拉米夫定）+特威凯（Tivicay®）的疗效和安全性：24周数据
BMC Pharmacol Toxicol. 2018 Oct 10;19(1):63. doi: 10.1186/s40360-018-0252-z.
4
Generalized semiparametric varying-coefficient model for longitudinal data with applications to adaptive treatment randomizations.用于纵向数据的广义半参数变系数模型及其在自适应治疗随机化中的应用。
Biometrics. 2017 Jun;73(2):441-451. doi: 10.1111/biom.12626. Epub 2016 Dec 5.
5
Systemic Cytokine Levels Do Not Predict CD4(+) T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection.系统性细胞因子水平不能预测慢性人类免疫缺陷病毒感染患者接受抑制性联合抗逆转录病毒治疗后的 CD4(+)T 细胞恢复情况。
Open Forum Infect Dis. 2016 Feb 8;3(1):ofw025. doi: 10.1093/ofid/ofw025. eCollection 2016 Jan.
6
Significantly improved HIV inhibitor efficacy prediction employing proteochemometric models generated from antivirogram data.运用基于抗病毒药物数据生成的药物化学计量模型，显著提高了 HIV 抑制剂疗效预测能力。
PLoS Comput Biol. 2013;9(2):e1002899. doi: 10.1371/journal.pcbi.1002899. Epub 2013 Feb 21.
7
Label free detection of CD4+ and CD8+ T cells using the optofluidic ring resonator.基于光流环形谐振器的 CD4+和 CD8+ T 细胞无标记检测。
Sensors (Basel). 2010;10(6):5798-808. doi: 10.3390/s100605798. Epub 2010 Jun 8.
8
Repositioning HIV protease inhibitors as cancer therapeutics.将HIV蛋白酶抑制剂重新定位为癌症治疗药物。
Curr Opin HIV AIDS. 2008 Nov;3(6):666-75. doi: 10.1097/COH.0b013e328313915d.
9
The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men.咨询策略对于提高男男性行为者坚持高效抗逆转录病毒治疗的成本效益分析
Med Decis Making. 2008 May-Jun;28(3):359-76. doi: 10.1177/0272989X07312714. Epub 2008 Mar 18.
10
Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children.含蛋白酶抑制剂的抗逆转录病毒疗法治疗HIV感染儿童后病毒与免疫结果不一致的临床意义
Immunol Res. 2008;40(3):271-86. doi: 10.1007/s12026-007-0031-1.